925 related articles for article (PubMed ID: 10764149)
1. Cytogenetic analogy between myelodysplastic syndrome and acute myeloid leukemia of elderly patients.
Rossi G; Pelizzari AM; Bellotti D; Tonelli M; Barlati S
Leukemia; 2000 Apr; 14(4):636-41. PubMed ID: 10764149
[TBL] [Abstract][Full Text] [Related]
2. Cytogenetic evolution following the transformation of myelodysplastic syndrome to acute myelogenous leukemia: implications on the overlap between the two diseases.
Ghaddar HM; Stass SA; Pierce S; Estey EH
Leukemia; 1994 Oct; 8(10):1649-53. PubMed ID: 7934160
[TBL] [Abstract][Full Text] [Related]
3. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001.
Mauritzson N; Albin M; Rylander L; Billström R; Ahlgren T; Mikoczy Z; Björk J; Strömberg U; Nilsson PG; Mitelman F; Hagmar L; Johansson B
Leukemia; 2002 Dec; 16(12):2366-78. PubMed ID: 12454741
[TBL] [Abstract][Full Text] [Related]
4. Myelodysplastic syndrome in children: differentiation from acute myeloid leukemia with a low blast count.
Chan GC; Wang WC; Raimondi SC; Behm FG; Krance RA; Chen G; Freiberg A; Ingram L; Butler D; Head DR
Leukemia; 1997 Feb; 11(2):206-11. PubMed ID: 9009082
[TBL] [Abstract][Full Text] [Related]
5. Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 7. European Working Group on MDS in Childhood (EWOG-MDS).
Hasle H; Aricò M; Basso G; Biondi A; Cantù Rajnoldi A; Creutzig U; Fenu S; Fonatsch C; Haas OA; Harbott J; Kardos G; Kerndrup G; Mann G; Niemeyer CM; Ptoszkova H; Ritter J; Slater R; Starý J; Stollmann-Gibbels B; Testi AM; van Wering ER; Zimmermann M
Leukemia; 1999 Mar; 13(3):376-85. PubMed ID: 10086728
[TBL] [Abstract][Full Text] [Related]
6. [Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].
Schmitt-Graeff A; Mattern D; Köhler H; Hezel J; Lübbert M
Pathologe; 2000 Jan; 21(1):1-15. PubMed ID: 10663664
[TBL] [Abstract][Full Text] [Related]
7. [Analysis on laboratory and clinical characteristics in 65 cases of myelodysplastic syndrome].
Chen BA; Gao C; Ding J; Ding JH; Sun YY; Zhao G; Cheng J; Wang J; Bao W; Song HH; Xia GH; Ma JL; Wu LL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1472-6. PubMed ID: 20030929
[TBL] [Abstract][Full Text] [Related]
8. Correlation of N-ras point mutations with specific chromosomal abnormalities in primary myelodysplastic syndrome.
de Souza Fernandez T; Menezes de Souza J; Macedo Silva ML; Tabak D; Abdelhay E
Leuk Res; 1998 Feb; 22(2):125-34. PubMed ID: 9593469
[TBL] [Abstract][Full Text] [Related]
9. Karyotype is prognostically more important than the FAB system's distinction between myelodysplastic syndrome and acute myelogenous leukemia.
Estey EH; Keating MJ; Dixon DO; Trujillo JM; McCredie KB; Freireich EJ
Hematol Pathol; 1987; 1(4):203-8. PubMed ID: 3504436
[TBL] [Abstract][Full Text] [Related]
10. Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly: confirmation of the existence of different entities with 11q23 breakpoint.
Archimbaud E; Charrin C; Magaud JP; Campos L; Thomas X; Fière D; Rimokh R
Leukemia; 1998 Jan; 12(1):25-33. PubMed ID: 9436917
[TBL] [Abstract][Full Text] [Related]
11. Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia.
Pedersen-Bjergaard J; Pedersen M; Roulston D; Philip P
Blood; 1995 Nov; 86(9):3542-52. PubMed ID: 7579462
[TBL] [Abstract][Full Text] [Related]
12. Identification of cytogenetic subclasses and recurring chromosomal aberrations in AML and MDS with complex karyotypes using M-FISH.
Van Limbergen H; Poppe B; Michaux L; Herens C; Brown J; Noens L; Berneman Z; De Bock R; De Paepe A; Speleman F
Genes Chromosomes Cancer; 2002 Jan; 33(1):60-72. PubMed ID: 11746988
[TBL] [Abstract][Full Text] [Related]
13. Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series.
Smith SM; Le Beau MM; Huo D; Karrison T; Sobecks RM; Anastasi J; Vardiman JW; Rowley JD; Larson RA
Blood; 2003 Jul; 102(1):43-52. PubMed ID: 12623843
[TBL] [Abstract][Full Text] [Related]
14. Karyotype in myelodysplastic syndromes: relations to morphology, clinical evolution, and survival.
Bernasconi P; Alessandrino EP; Boni M; Bonfichi M; Morra E; Lazzarino M; Campagnoli C; Astori C
Am J Hematol; 1994 Aug; 46(4):270-7. PubMed ID: 8037176
[TBL] [Abstract][Full Text] [Related]
15. Primary myelodysplasia occurring in adults under 50 years old: a clinicopathologic study of 52 patients.
Chang KL; O'Donnell MR; Slovak ML; Dagis AC; Arber DA; Niland JC; Forman SJ
Leukemia; 2002 Apr; 16(4):623-31. PubMed ID: 11960342
[TBL] [Abstract][Full Text] [Related]
16. Results of chromosome studies and their relation to morphology, course, and prognosis in 120 patients with de novo myelodysplastic syndrome.
Suciu S; Kuse R; Weh HJ; Hossfeld DK
Cancer Genet Cytogenet; 1990 Jan; 44(1):15-26. PubMed ID: 2293879
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetic analysis of de novo acute myeloid leukemia with trilineage myelodysplasia in comparison with myelodysplastic syndrome evolving to acute myeloid leukemia.
Tamura S; Takemoto Y; Hashimoto-Tamaoki T; Mimura K; Sugahara Y; Senoh J; Furuyama JI; Kakishita E
Int J Oncol; 1998 Jun; 12(6):1259-62. PubMed ID: 9592183
[TBL] [Abstract][Full Text] [Related]
18. The WHO 2016 diagnostic criteria for Acute Myeloid leukemia with myelodysplasia related changes (AML-MRC) produce a very heterogeneous entity: A retrospective analysis of the FAB subtype RAEB-T.
Kaivers J; Peters J; Rautenberg C; Schroeder T; Kobbe G; Hildebrandt B; Haas R; Germing U; Bennett JM
Leuk Res; 2022 Jan; 112():106757. PubMed ID: 34864369
[TBL] [Abstract][Full Text] [Related]
19. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
[TBL] [Abstract][Full Text] [Related]
20. Hematologic, clinical, and cytogenetic analysis in 109 patients with primary myelodysplastic syndrome. Prognostic significance of morphology and chromosome findings.
Parlier V; van Melle G; Beris P; Schmidt PM; Tobler A; Haller E; Bellomo MJ
Cancer Genet Cytogenet; 1994 Dec; 78(2):219-31. PubMed ID: 7828157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
